International Cancer Research Conference
March 24-26, 2025 | Singapore
Advances In Cancer Research And Treatment
Cancer research and patient treatment faced a number of unforeseen hurdles in 2020. Cancer research has been halted, clinical studies have been postponed, appointments have been rescheduled, and conferences have been cancelled or restructured. Rapid research advancements were made possible by unprecedented levels of scientific collaboration and dissemination. In 2020, the US Food and Drug Administration (FDA) authorized twenty-one novel oncology medications, including treatments for difficult-to-treat diseases such triple-negative breast cancer and some gastrointestinal stromal tumors. The first liquid biopsy next-generation sequencing tests were approved, the first-in-human study of off-the-shelf CAR T-cell treatment began, and the American Association for Cancer Research (AACR) published its first comprehensive report on cancer disparities.
- Vaccinating cancer patients
- Cancer disparities
- Cancer prevention
- Immunotherapy
- Precision medicine
- Cancer treatment
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
Seattle Children’s Hospital, United States
Michael Thompson
University of Toronto, Canada
Kaushala Prasad Mishra
Asian Association for Radiation Research (AARR), India
Mariola Wioletta Borowska
Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Andrea González Báez
Autonomous University of Nuevo Leon, Mexico
Qian Zhang
The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, ChinaSubmit your abstract Today
Title :
Patricia Tai, Saskatchewan Cancer Agency, Canada
Title :
Atif A Ahmed, Seattle Children’s Hospital, United States
Title :
Marika Crohns, Sanofi, Germany
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada